HEADER SIGNALING PROTEIN/TRANSCRIPTION 22-MAR-11 2LAY TITLE STRUCTURE OF THE FIRST WW DOMAIN OF HUMAN YAP IN COMPLEX WITH A TITLE 2 PHOSPHORYLATED HUMAN SMAD1 DERIVED PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: YORKIE HOMOLOG; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 170-205; COMPND 5 SYNONYM: 65 KDA YES-ASSOCIATED PROTEIN, YAP65; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: MOTHERS AGAINST DECAPENTAPLEGIC HOMOLOG 1; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: RESIDUES 201-209; COMPND 11 SYNONYM: MAD HOMOLOG 1, MOTHERS AGAINST DPP HOMOLOG 1, JV4-1, MAD- COMPND 12 RELATED PROTEIN 1, SMAD FAMILY MEMBER 1, SMAD 1, SMAD1, HSMAD1, COMPND 13 TRANSFORMING GROWTH FACTOR-BETA-SIGNALING PROTEIN 1, BSP-1; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: YAP1, YAP65; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR: PETM11; SOURCE 9 MOL_ID: 2; SOURCE 10 SYNTHETIC: YES; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606 KEYWDS YAP, SMAD, CDK, SIGNAL TRANSDUCTION, SIGNALING PROTEIN-TRANSCRIPTION KEYWDS 2 COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR M.J.MACIAS,E.ARAGON,N.GOERNER,A.ZAROMYTIDOU,Q.XI,A.ESCOBEDO, AUTHOR 2 J.MASSAGUE REVDAT 2 27-NOV-24 2LAY 1 REMARK LINK REVDAT 1 06-JUL-11 2LAY 0 JRNL AUTH E.ARAGON,N.GOERNER,A.I.ZAROMYTIDOU,Q.XI,A.ESCOBEDO, JRNL AUTH 2 J.MASSAGUE,M.J.MACIAS JRNL TITL A SMAD ACTION TURNOVER SWITCH OPERATED BY WW DOMAIN READERS JRNL TITL 2 OF A PHOSPHOSERINE CODE. JRNL REF GENES DEV. V. 25 1275 2011 JRNL REFN ISSN 0890-9369 JRNL PMID 21685363 JRNL DOI 10.1101/GAD.2060811 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.3, CNS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-KUNSTLEVE,JIANG, REMARK 3 KUSZEWSKI,NILGES, PANNU,READ,RICE,SIMONSON,WARREN (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2LAY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-APR-11. REMARK 100 THE DEPOSITION ID IS D_1000102174. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 285 REMARK 210 PH : 7 REMARK 210 IONIC STRENGTH : 0.420 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 1 MM NEDD4LWW3, 3 MM SMAD3, 20 REMARK 210 MM SODIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 2 MM SODIUM REMARK 210 AZIDE, 90% H2O/10% D2O; 1 MM [U- REMARK 210 100% 15N] NEDD4LWW3, 3 MM SMAD3, REMARK 210 20 MM SODIUM PHOSPHATE, 100 MM REMARK 210 SODIUM CHLORIDE, 2 MM SODIUM REMARK 210 AZIDE, 90% H2O/10% D2O; 1 MM [U- REMARK 210 100% 13C; U-100% 15N] NEDD4LWW3, REMARK 210 3 MM SMAD3, 20 MM SODIUM REMARK 210 PHOSPHATE, 100 MM SODIUM REMARK 210 CHLORIDE, 2 MM SODIUM AZIDE, 90% REMARK 210 H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-1H NOESY; 2D 1H-1H TOCSY; REMARK 210 3D CBCA(CO)NH; 3D HNCACB; 2D 1H- REMARK 210 15N HSQC REMARK 210 SPECTROMETER FIELD STRENGTH : 600 MHZ REMARK 210 SPECTROMETER MODEL : DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : XEASY, TOPSPIN, NMRPIPE REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 300 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 PRO B 204 -141.41 -90.19 REMARK 500 2 THR B 202 15.81 -140.88 REMARK 500 2 PRO B 204 -125.79 -79.01 REMARK 500 2 HIS B 205 25.29 -150.03 REMARK 500 2 SEP B 206 150.29 54.59 REMARK 500 3 PRO B 204 -135.79 -85.44 REMARK 500 4 PRO B 204 -133.42 -83.10 REMARK 500 4 SEP B 206 159.39 54.61 REMARK 500 5 PRO B 204 -111.02 -84.92 REMARK 500 6 LEU A 173 -72.68 -98.45 REMARK 500 6 PRO B 204 -126.64 -69.70 REMARK 500 6 SEP B 206 140.02 60.28 REMARK 500 7 THR B 202 20.93 -150.02 REMARK 500 7 PRO B 204 -156.61 -84.53 REMARK 500 7 PRO B 207 -71.96 -46.13 REMARK 500 7 THR B 208 -158.05 -132.70 REMARK 500 8 PRO B 204 -133.47 -76.62 REMARK 500 8 HIS B 205 43.37 -148.48 REMARK 500 8 SEP B 206 145.15 61.87 REMARK 500 9 PRO B 204 -108.56 -91.46 REMARK 500 10 PRO B 204 -145.68 -91.11 REMARK 500 11 TRP A 177 -167.73 -169.61 REMARK 500 11 ASP A 201 103.92 58.46 REMARK 500 11 PRO B 204 -114.60 -84.88 REMARK 500 12 PRO B 204 -145.85 -84.32 REMARK 500 12 SEP B 206 141.86 64.90 REMARK 500 13 PRO B 204 -144.12 -74.94 REMARK 500 14 PRO A 172 -9.92 -58.84 REMARK 500 14 HIS A 192 3.58 -69.36 REMARK 500 14 ASP A 201 99.61 62.57 REMARK 500 14 PRO B 204 -158.54 -82.79 REMARK 500 15 GLN A 195 74.59 55.54 REMARK 500 15 PRO B 204 -139.43 -81.52 REMARK 500 16 TRP A 177 -169.11 -160.24 REMARK 500 16 PRO B 204 -131.62 -84.93 REMARK 500 16 HIS B 205 27.15 -143.24 REMARK 500 16 SEP B 206 132.32 53.45 REMARK 500 17 GLN A 195 32.58 70.18 REMARK 500 17 LYS A 204 -72.91 -74.23 REMARK 500 17 PRO B 204 -154.75 -90.71 REMARK 500 18 PRO B 204 -124.15 -85.58 REMARK 500 18 HIS B 205 20.08 -149.88 REMARK 500 18 SEP B 206 144.54 56.49 REMARK 500 18 PRO B 207 -75.14 -64.44 REMARK 500 18 THR B 208 84.45 -150.23 REMARK 500 19 HIS A 192 1.63 -68.40 REMARK 500 19 PRO B 204 -121.03 -83.56 REMARK 500 20 THR B 202 -44.34 -150.02 REMARK 500 20 PRO B 204 -110.65 -62.20 REMARK 500 20 HIS B 205 3.11 -150.06 REMARK 500 REMARK 500 THIS ENTRY HAS 51 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 17540 RELATED DB: BMRB REMARK 900 RELATED ID: 2LAW RELATED DB: PDB REMARK 900 RELATED ID: 2LAX RELATED DB: PDB REMARK 900 RELATED ID: 2LAZ RELATED DB: PDB REMARK 900 RELATED ID: 2LB0 RELATED DB: PDB REMARK 900 RELATED ID: 2LB1 RELATED DB: PDB REMARK 900 RELATED ID: 2LB2 RELATED DB: PDB REMARK 900 RELATED ID: 2LB3 RELATED DB: PDB DBREF 2LAY A 170 205 UNP P46937 YAP1_HUMAN 170 205 DBREF 2LAY B 201 209 UNP Q15797 SMAD1_HUMAN 201 209 SEQRES 1 A 36 ASP VAL PRO LEU PRO ALA GLY TRP GLU MET ALA LYS THR SEQRES 2 A 36 SER SER GLY GLN ARG TYR PHE LEU ASN HIS ILE ASP GLN SEQRES 3 A 36 THR THR THR TRP GLN ASP PRO ARG LYS ALA SEQRES 1 B 9 SER THR TYR PRO HIS SEP PRO THR SER MODRES 2LAY SEP B 206 SER PHOSPHOSERINE HET SEP B 206 14 HETNAM SEP PHOSPHOSERINE HETSYN SEP PHOSPHONOSERINE FORMUL 2 SEP C3 H8 N O6 P SHEET 1 A 3 TRP A 177 THR A 182 0 SHEET 2 A 3 GLN A 186 ASN A 191 -1 O LEU A 190 N GLU A 178 SHEET 3 A 3 THR A 196 THR A 198 -1 O THR A 196 N ASN A 191 LINK C HIS B 205 N SEP B 206 1555 1555 1.33 LINK C SEP B 206 N PRO B 207 1555 1555 1.35 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1